Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis

The introduction of S1P receptor modulators and JAK inhibitors for UC has the potential to revolutionize the therapeutic landscape. Join us as expert faculty discuss the place in therapy for these agents to help improve clinical and patient-oriented health outcomes.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.